Novo Nordisk (NVO.N) CEO said the company will outline at its capital markets day how it plans to accelerate development of early-stage assets and early-stage science.

2026-08-05

Novo Nordisk (NVO.N) CEO said the company will outline at its capital markets day how it plans to accelerate development of early-stage assets and early-stage science.